sk&f 77434 has been researched along with ergoline in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, JP; Peter, RE; Wong, AO | 1 |
Garrett, BE; Holtzman, SG | 1 |
Kamijo, N; Nagao, T; Ono, H | 1 |
Bergman, J; Tidey, JW | 1 |
4 other study(ies) available for sk&f 77434 and ergoline
Article | Year |
---|---|
Dopamine stimulates growth hormone release from the pituitary of goldfish, Carassius auratus, through the dopamine D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Domperidone; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Goldfish; Gonadotropin-Releasing Hormone; Growth Hormone; Pituitary Gland; Quinpirole; Radioimmunoassay; Receptors, Dopamine | 1992 |
Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Analysis of Variance; Animals; Apomorphine; Caffeine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Ergolines; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1994 |
Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzamides; Bromocriptine; Decerebrate State; Depression, Chemical; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Reflex, Monosynaptic; Sulpiride; Synaptic Transmission | 1993 |
Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Agents; Animals; Benzazepines; Catalepsy; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Ergolines; Male; Methamphetamine; Oxazines; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri | 1998 |